The US is the bigger Bone & Joint Health Supplements market: $5 Bn against $965 Mn in 2023, about 5.2 times as large.
China grows faster: 7.9% a year, against 4.4%. The gap still grows from $4.1 Bn to $5.7 Bn by 2033.
Clinical research: 8 active trials in the US, 1 in China.
| Measure |  US |  China |
|---|---|---|
| Market size, 2023 | $5 Bn | $965 Mn |
| Market size, 2033 projected | $7.8 Bn | $2.1 Bn |
| Growth a year (CAGR) | 4.4% | 7.9% |
| Money added, 2023–2033 | $2.7 Bn | $1.1 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $15 | $0.69 |
| Active clinical trials | 8 | 1 |
| Full report | US report | China report |
Year by year, 2023 to 2033
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
Quick answers
Which is bigger in Bone & Joint Health Supplements, US or China?
The US is the bigger Bone & Joint Health Supplements market: $5 Bn against $965 Mn in 2023, about 5.2 times as large.
Which grows faster in Bone & Joint Health Supplements, US or China?
China grows faster: 7.9% a year, against 4.4%. The gap still grows from $4.1 Bn to $5.7 Bn by 2033.
More Bone & Joint Health Supplements comparisons
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.